"Patients presenting with chronic diarrhea, blood in the stool, unexplained nausea and vomiting, or unexplained weight loss ...

Maintenance therapy with lurbinectedin (lurbi) and atezolizumab (atezo) helps some patients with extensive-stage small cell ...

A new antibiotic that has the potential to save millions of lives has entered its last phase of human testing. Swiss ...

GlycoEra’s lead candidate targets IgG4 autoantibodies, potentially addressing autoimmune diseases such as muscle-specific ...

An experimental antibiotic zosurabalpin to fight deadly superbug has entered the final human trials. This development could ...

Applied Cognition, a clinical-stage platform therapeutic company, today announced the publication of a groundbreaking study ...

Thwarted in her ambition to become a brewmaster, Kiran Mazumdar-Shaw channeled her frustrations into building a knockoff drug ...

BioNTech SE (Nasdaq: BNTX, "BioNTech” or "the Company”) will present clinical trial data from select pipeline candidates across the Company's diversified oncology portfolio at the American Society of ...

A new antibiotic that could treat a common ‘superbug’ is to be tested on patients. The drug Zosurabalpin, is being developed ...

The global allergy treatment market is expected to grow at a CAGR of 6-7% in the coming years, driven by factors such as ...

The first new antibiotic in 50 years to tackle a common superbug is entering its final phase of human testing. Swiss ...